Results 141 to 150 of about 4,608 (197)

[18F]SiTATE PET for PRRT selection and monitoring metastatic tumors of the adrenal medulla and extra-adrenal paraganglia

open access: green
Sophie C. Kunte   +16 more
openalex   +1 more source

PRRT Retreatments: Renal Function Evaluation

open access: yes, 2019
Riccardo Laudicella   +9 more
openaire   +3 more sources

Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and Outcomes. [PDF]

open access: yesCancers (Basel)
Lewetag RD   +11 more
europepmc   +1 more source

<sup>177</sup>Lu-PRRTを行ったACTH産生嗅神経芽細胞腫の1例

open access: diamond
雄幸 藤島   +6 more
openalex   +2 more sources

Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review. [PDF]

open access: yesCancers (Basel)
Hernandez-Felix JH   +5 more
europepmc   +1 more source

Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)

open access: hybrid, 2018
Vikas Prasad   +11 more
openalex   +1 more source

AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Laudicella R   +21 more
europepmc   +1 more source

PRRT in high‐grade digestive neuroendocrine neoplasms ( NET G3 and NEC ) [PDF]

open access: hybrid
Halfdan Sørbye   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy